Manufacturing CFOs Prioritize Technology Talent and Tariffs in 2026 According to Forvis Mazars
Silver Market Consolidates as Investors Await US PCE and GDP Data Amid Stabilizing Real Yields
Putin and Xi Set to Discuss LongStalled Power of Siberia 2 Pipeline Amid Iran Conflicts Energy Shockwaves
Berkshire Hathaway Rebuilds Airline Position with 26 Billion Delta Air Lines Stake
Tech Titans Shift White House AI Policy Revealing Rift Within Conservative Base
Bill Gates Discusses Trump Meeting Musks DOGE and Childhood in WSJ Interview
RGR Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Uptick
Red Violet Inc RDVT Q1 2026 Earnings EPS Surges 409 Above Estimates Amid Strong Operational Execution
ASPI Q4 2025 Earnings Significant EPS Miss Overshadowed by Strong Stock Rally
CLLS Q1 2026 Earnings Narrowing Losses as Cost Discipline Surprises to the Upside
ALEC Q1 2026 Earnings NarrowerthanExpected Loss Drives Positive Market Response
FMNB Q1 2026 Earnings Strong EPS Surprise of 212 Drives Investor Attention Despite Stock Dip
SPX Technologies SPXC Declines 171 Support and Resistance Levels in Focus
Akanda Corp AKAN Plunges 12 Key Levels to Watch Amid Cannabis Sector Volatility
Alnylam Pharmaceuticals ALNY Holds Near Support Amid Modest Decline
Asbury Automotive Group ABG Gains 218 as Stock Tests Key Resistance Zone
AllianceBernstein AB Slips 134 as Pressure Mounts Near Key Support Levels
Vertical Aerospace EVTL Why the eVTOL Developer Represents a Classic HighRisk Market Play
Corvex Inc MOVE Q1 2026 Earnings EPS Beat Boosts Shares as Loss Narrows
Federal Signal Corporation FSS Gains Ground Approaching Key Resistance Amid Strong Volume
Marsh MRSH Holds Near 160 as Modest Decline Tests ShortTerm Support
First Citizens BancShares Preferred FCNCN Steady Trading Near Midpoint of Range
Power Solutions International PSIX Declines Amid Sector Headwinds Key Support Levels Eyed
PML Shares Edge Higher as Municipal Bond Market Stabilizes
Park Hotels Resorts PK Climbs 1 as It Approaches Key Resistance Level
Precision Drilling PDS Holds Steady Near 96 Consolidation Within Established Range
Autolus Therapeutics AUTL Advances 394 as Momentum Builds Toward Key Resistance